[{"indications": "Indications\u00a0short-term treatment of mild to moderate atopic eczema (including\r\nflares) when topical corticosteroids cannot be used; see also notes above", "name": "PIMECROLIMUS", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "13 Skin", "13.5 Preparations for eczema and psoriasis", "13.5.3 Drugs affecting the immune response", "PIMECROLIMUS"], "cautions": "Cautions\u00a0UV light (avoid excessive exposure to\r\nsunlight and sunlamps), avoid other topical\r\ntreatments except emollients at treatment site; alcohol consumption (risk of facial flushing and skin irritation)", "side-effects": "Side-effects\u00a0burning sensation, pruritus, erythema, skin infections\r\n(including folliculitis and less commonly impetigo,\r\nherpes simplex and zoster, molluscum contagiosum); rarely papilloma, skin discoloration, local reactions including pain, paraesthesia,\r\npeeling, dryness, oedema, and worsening of eczema; skin malignancy\r\nreported", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/119692.htm", "doses": ["Short-term treatment, apply twice daily until symptoms\r\nresolve (stop treatment if eczema worsens or no response after 6 weeks); child under 2 years not recommended"]}]